GLP-1 and bioidentical hormone replacement therapy within a structured care plan
If you are researching GLP-1 medication, bioidentical hormone replacement therapy, or both — you do not need to arrive knowing which is right for you. What matters is that you are looking for a provider who prescribes with clinical rigor, not convenience.
You already know what careless prescribing looks like. Telehealth platforms that dispense GLP-1s after a questionnaire. An OB/GYN who prescribes hormone replacement without evaluating your insulin resistance, body composition, or full metabolic profile. You have been looking for something more serious.
One provider. One clinical relationship. Every medication — GLP-1, bioidentical hormones, and others — managed within the full context of your metabolic and hormonal health. Prescribed based on a comprehensive intake and diagnostic evaluation. Monitored at every visit.
This page explains our clinical approach to prescribing and why the sequence of care matters.
How we prescribe
Every medication we prescribe follows the same logic: evaluation before intervention. Medication is never a standalone solution; it is one component of a structured program that includes nutrition, exercise, movement, and nervous system support.
The sequence matters because the same medication can produce very different outcomes depending on when it is introduced. A GLP-1 prescribed before the metabolic foundation is in place often produces weight loss at the expense of muscle — the tissue that drives your long-term metabolic durability. Bioidentical hormones prescribed without evaluating the underlying metabolic picture may address symptoms but do nothing to resolve the dysfunction beneath them.
The Metabolic Evaluation identifies your specific patterns; the order of intervention follows from there.
GLP-1 as strategic scaffolding
We prescribe compounded semaglutide and tirzepatide when clinically indicated — as a strategic tool within a structured care plan, not a first resort. Three clinical commitments shape how the medication enters, how it is monitored, and how it ends.
The clinical sequence
GLP-1 is never the first intervention. The first four weeks of the Metabolic Rebuild establish your foundation — protein, sleep, movement, and nervous system support come first. Medication enters only when that foundation can support productive fat loss, and only if it is clinically indicated and aligned with what you want from your care. The order matters: a GLP-1 prescribed before the metabolic foundation is in place often produces weight loss at the expense of muscle, the tissue that drives your long-term metabolic durability.
Consistent monitoring
Your response is tracked and your dosing adjusted biweekly, using both objective and subjective data — metabolic markers, side effects, and your daily experience of the medication. Dosing follows your trends, not a standard titration schedule. This is where the difference between a structured care plan and a prescription mill becomes visible: your provider is reviewing two weeks of data at every visit, not handing you a calendar of dose escalations.
The exit plan
The goal is metabolic stability after the medication ends, not indefinite GLP-1 dependence. A monitored taper begins when your body composition and metabolic stability support it. Resistance training and direct lean mass tracking protect the muscle tissue that drives long-term metabolic durability throughout the program — not just at the end. By the time you taper, you have the metabolic skills to keep the results: how to read your own glucose response, how to recognize when sleep or stress are eroding your progress, how to recalibrate before something becomes a setback.
BHRT as ongoing care
We prescribe bioidentical hormone replacement therapy (BHRT) when clinically indicated — individualized to your labs and symptoms. Three clinical commitments shape how BHRT enters your plan, how it is monitored, and how it integrates with the rest of your care.
Individualized timing
Your metabolic and hormonal health are assessed together from day one — not as separate concerns managed by separate providers. The evaluation determines when BHRT enters your plan. If estrogen decline is driving your metabolic instability, BHRT enters early — addressing the hormonal driver is what allows the metabolic foundation to take hold. If hormonal symptoms are downstream of insulin resistance, we address the metabolic foundation first, because resolving insulin resistance often resolves a meaningful portion of the hormonal picture before additional intervention is needed.
Ongoing clinical rigor
BHRT is not a once-a-year prescription written and forgotten. Labs are reassessed every three months during dose titration, and annually once your levels have remained stable for more than six months. Your response is reviewed at every visit — symptom resolution, side effects, your sense of how the dose is working — and the formulation is adjusted as your hormonal status evolves through perimenopause and menopause.
The integrated medical home
Your OB/GYN provides essential screenings and gynecologic care. We manage the metabolic and hormonal picture: weight, insulin resistance, body composition, and hormone replacement therapy considered together as the one system that they are. If you arrive on HRT from another provider, we can transition you to compounded bioidenticals when that fits your clinical picture, or integrate your existing prescription into your care plan if you want to remain on it.
The integrated regimen
This is not a medication menu; it is a clinical partnership. While GLP-1s and BHRT are the medications patients ask about the most, they are only part of the picture. Thyroid function, blood pressure, lipid markers, insulin response — and the broader state of your metabolic health that is surfaced by the Metabolic Evaluation — are all part of the same system. We manage them all in one place, alongside any prescriptions you already have from other providers, so your care fits into one cohesive plan rather than running on parallel tracks.
Where medication management begins
Whether you came to this page researching GLP-1 medication, bioidentical hormone replacement therapy, or both — the pathway forward is the same. The Metabolic Evaluation maps your full picture, identifies your pattern, and is where every prescribing decision begins.
Every medication we prescribe is grounded in a comprehensive Metabolic Evaluation, sourced from a quality-certified compounding pharmacy, and managed through the ongoing clinical relationship of the Metabolic Rebuild or Continued Care. We do not prescribe outside an active clinical relationship.
The Metabolic Evaluation
A 60-minute intake and comprehensive lab assessment followed by a 45-minute review of findings with specific clinical recommendations.
Schedule a Metabolic EvaluationThe Discovery Visit
A conversation to talk through what you are experiencing and whether this is the right clinical fit.
Schedule a Discovery Visit